drugset / Trial / NCT00887549

A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

NCT00887549 ↗

Phase 2 Completed 70 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelTreatment

Summary

Thymidylate synthase (TS) is a substance the body produces naturally. The purpose of this research is to determine if there is a link between TS production and how well patients respond to treatment of non-squamous non-small cell lung cancer (NSCLC). The aim for the future is that doctors could have a better understanding in advance about which patients might respond well to pemetrexed based on how much TS they produce.

Timeline

Start
2009-04
Primary completion
2010-07
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pemetrexed Small molecule 500 mg/m2 Intravenous
Background Cisplatin Other / unclassified 75 mg/m2 Intravenous